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A 38 year-old man was admitted with vasculitic rash and horizontal diplopia nine months post allogenic stem cell 
transplantation for T-cell acute lymphoblastic leukemia (ALL). Magnetic resonance (MR) of the orbits showed enlarged 
extra-ocular muscles and an echocardiogram, to exclude cardiac embolic sources, showed bi-ventricular hypertrophy 
and speckled myocardium. A 12-lead ECG showed diffuse T-wave inversion (Panel 1A). A cardiovascular MR (CMR) 
showed preserved bi-ventricular systolic function, septal left ventricular (LV) hypertrophy (max 21 mm, normal 
<12mm) (Panel 1B) with increased LV mass (88 g/m2, normal 48-77 g/m2). Multiple areas of myocardial and 
pericardial infiltration (n=9, largest 18x50mm) were noted on advanced tissue characterisation, showing markedly 
increased T1 values on native T1 mapping, and non-enhancing after contrast administration (Panel 1C and D, white 
arrows). The CMR findings raised the suspicion of acute cardiac involvement of ALL.  A MR-guided biopsy of the 
swollen ocular left rectus muscle confirmed the diagnosis of relapsed acute T-cell ALL (Panel 2A and B), further 
supported by evidence of 0.09% T-lymphoblasts on bone marrow flow cytometry and low level central nervous system 
(CNS) disease on lumbar puncture. As all the investigations confirmed acute multi-organ ALL relapse (heart, extra-
ocular muscles, bone marrow and CNS), systemic chemotherapy with nelarabine and intra-thecal cytosine arabinoside 
were started. Diplopia rapidly improved, and a repeat orbit MR 14 days after commencement of chemotherapy showed 
complete resolution of extra-ocular muscle enlargement. A 1-month repeat CMR to assess cardiac response 
demonstrated complete resolution of all nodular lesions with normalization of LV wall thickness (10 mm) and mass (60 
g/m2) (Panel 3 B, C and D), and of the widespread T-wave inversion on ECG (Panel 3A). 
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